CuraScientific Corp.
CSTF
$0.00
$0.000.00%
| Weiss Ratings | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.02 | |||
| Price History | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.50% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 08, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.53K | |||
| Enterprise Value | 3.22M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -100.06% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 4.79 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -1.96 | |||
| Enterprise Value/EBIT | -1.11 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 756.68M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 909 435 1642 | |||
| Address | 51544 Cesar Chavez Street Coachella, CA 92236 | |||
| Website | www.curascientificcorp.com | |||
| Country | United States | |||
| Year Founded | 2022 | |||
| Profitability | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -432.76% | |||
| Profit Margin | 5,014.69% | |||
| Management Effectiveness | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -109.44% | |||
| Return on Equity | -- | |||
| Income Statement | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 671.70K | |||
| Total Revenue (TTM) | 671.70K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -1.37M | |||
| EBITDA (TTM) | -1.64M | |||
| EBIT (TTM) | -2.91M | |||
| Net Income (TTM) | 33.68M | |||
| Net Income Avl. to Common (TTM) | 33.68M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -3,045.13% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -125.00% | |||
| Balance Sheet | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 40.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.08M | |||
| Total Preferred Equity (Q) | 2.52 | |||
| Total Equity (Q) | -24.78M | |||
| Current Ratio (Q) | 0.041 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 1.62M | |||
| Total Current Liabilities (Q) | 26.06M | |||
| Total Debt (Q) | 733.90K | |||
| Total Liabilities (Q) | 26.40M | |||
| Total Common Equity (Q) | -27.30M | |||
| Cash Flow | CSTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -21.00K | |||
| Cash from Financing (TTM) | 366.00K | |||
| Net Change in Cash (TTM) | 40.80K | |||
| Levered Free Cash Flow (TTM) | -43.16M | |||
| Cash from Operations (TTM) | -304.20K | |||
